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Abstract
Introduction—Pharmacy stores are positioned to cultivate health and wellness among patrons. 
This study assessed attitudes toward prohibiting tobacco product sales in pharmacy stores among 
U.S. adults.
Methods—Data from the 2014 Summer Styles, an Internet survey of U.S. adults aged ≥18 years 
(n=4,269), were analyzed in 2015. Respondents were asked: Do you favor or oppose banning the 
sale of all tobacco products in retail pharmacy stores? Responses were: strongly favor, somewhat 
favor, somewhat oppose, and strongly oppose. Prevalence ratios were calculated using multivariate 
Poisson regression to determine sociodemographic correlates of favorability (strongly or 
somewhat).
Results—Among all adults, 66.1% “strongly” or “somewhat” favored prohibiting tobacco 
product sales in pharmacy stores. Favorability was 46.5% among current cigarette smokers, 66.3% 
among former smokers, and 71.8% among never smokers. Favorability was 47.8% among current 
non-cigarette tobacco users, 63.2% among former users, and 71.4% among never users. Following 
adjustment, favorability was more likely among women compared with men (p < 0.05). 
Conversely, favorability was less likely among the following: adults aged 25–44 years and 45–64 
years compared with those aged ≥65 years, those with annual household income of $15,000–
$24,999 compared with ≥$60,000, current cigarette smokers compared with never smokers, and 
current and former non-cigarette tobacco users compared with never tobacco users (p < 0.05).
Conclusions—Most U.S. adults favor prohibiting tobacco sales in retail pharmacy stores. 
Eliminating tobacco product sales in these settings may reinforce pharmacy stores’ efforts to 
promote wellness, and further cultivate social climates that reduce the desirability, acceptability, 
and accessibility of tobacco.
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Pharmacy stores are positioned to cultivate health and wellness among patrons. However, 
many U.S. pharmacies sell and advertise tobacco, the nation’s leading preventable cause of 
death and disease.1 This is an established concern among pharmacists, whose professional 
obligation is to promote their patients’ health.2–4
Just as pharmacists’ attitudes can shape tobacco-free practices,5 public attitudes toward 
tobacco control interventions can inform policy development, implementation, and 
sustainment. Previous studies have documented general public favorability toward tobacco-
related sales restrictions in pharmacy stores at national and local levels, and variations in 
favorability by sociodemographic characteristics and cigarette smoking status.6,7 However, 
increasingly more communities across the U.S. have since implemented policies that 
prohibit the sale of tobacco products in these settings.8 Moreover, the tobacco product 
landscape continues to diversify, and no study has assessed variations in public attitudes 
toward such policies by other forms of tobacco product use beyond cigarettes. Accordingly, 
this study assessed the prevalence and determinants of favorability toward prohibiting the 
sale of tobacco products in pharmacy stores among a nationally representative sample of 
U.S. adults in 2014.
Methods
Data Source
Data came from Summer Styles, a web-based survey conducted by Porter Novelli to explore 
health behaviors and attitudes among U.S. adults aged ≥18 years. Styles respondents are 
drawn from the nationally representative KnowledgePanel®, which uses probability-based 
sampling to recruit online panelists regardless of landline phone or Internet access. As 
described previously, Summer Styles is sent to a stratified random sample of respondents, 
and data are weighted to be nationally representative using Current Population Survey 
distributions.9 In 2014 (June–July), 4,269 respondents completed Summer Styles, yielding a 
69% response rate. This secondary analysis of de-identified data was exempt from human 
subjects review.
Measures
Participants were asked: Do you favor or oppose banning the sale of all tobacco products in 
retail pharmacy stores? Adults who responded strongly favor or somewhat favor were 
considered to favor a policy prohibiting all tobacco sales in pharmacy stores. Favorability 
was assessed by cigarette smoking status, non-cigarette tobacco product use (i.e., cigars or 
big cigars; cigarillos; little cigars; chewing tobacco, snuff, or dip; electronic cigarettes or e-
cigarettes; electronic hookahs, hookah pens, or vape pens; some other electronic vapor 
product such as electronic cigars or electronic pipes; water pipes; roll-your-own cigarettes; 
flavored cigars; snus; dissolvable tobacco), and sociodemographics (sex, age, race/ethnicity, 
education, annual household income, and U.S. region).
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Point estimates and 95% CIs were calculated overall and by sociodemographics, cigarette 
smoking status, and non-cigarette tobacco product use. Multivariate Poisson regression was 
used to calculate adjusted prevalence ratios (APRs) of the association between favorability 
and sociodemographics, cigarette smoking, and non-cigarette tobacco use. Analyses were 
conducted in 2015 using R, version 3.2.2.
Results
Overall, 66.1% of U.S. adults favored (“strongly” or “somewhat”) prohibiting tobacco 
product sales in pharmacy stores; 20.1% “somewhat opposed” and 13.8% “strongly 
opposed” the idea (Table 1). Prevalence of favorability was 62.2% among men and 69.7% 
among women. Favorability ranged from 63.7% among adults aged 25–44 years to 72.2% 
among adults aged ≥65 years; from 64.6% among non-Hispanic blacks to 70.4% among 
non-Hispanic other races; from 61.7% among adults with less than a high school education 
to 70.1% among those with a college degree; from 48.0% among adults with annual 
household income <$15,000 to 69.0% among adults with income ≥$60,000; and from 63.9% 
in the South to 70.2% in the West. Favorability was 46.5% among current cigarette smokers, 
66.3% among former smokers, and 71.8% among never smokers. Favorability was 47.8% 
among current non-cigarette tobacco users, 63.2% among former non-cigarette tobacco 
users, and 71.4% among never non-cigarette tobacco users.
The adjusted likelihood of favorability was greater among women than men (APR=1.08, 
95% CI=1.03, 1.14) (Table 2). The likelihood of favorability was lower among those aged 
25–44 years (APR=0.91, 95% CI=0.86, 0.98) and 45–64 years (APR=0.94, 95% CI=0.88, 
0.99) than those aged ≥65 years; among those with annual household income <$15,000 
(APR=0.82, 95% CI=0.71, 0.94) than those with income ≥$60,000; among current cigarette 
smokers (APR=0.73, 95% CI=0.65, 0.82) than never smokers; and among current 
(APR=0.80, 95% CI=0.70, 0.92) or former (APR=0.93, 95% CI=0.87, 0.99) non-cigarette 
tobacco users than never users.
Discussion
This study reveals that two thirds of U.S. adults, including nearly half of cigarette smokers 
and non-cigarette tobacco users, favor prohibiting the sale of tobacco products in retail 
pharmacy stores. A majority of all assessed sociodemographic groups favored prohibiting 
tobacco sales in pharmacies, but the likelihood of favoring such a policy was lower among 
adults aged 25–44 years and 45–64 years, and among adults with annual income <$15,000. 
These findings are generally consistent with previous surveys, which indicate cigarette 
smokers are less likely to have favorable attitudes toward tobacco-related sales restrictions in 
pharmacies.6,7 However, this study is the first to document that current users of non-cigarette 
tobacco products are also less likely to demonstrate favorability for such policies than never 
users. Non-cigarette tobacco product users are an important subgroup to consider, as 
tobacco-free pharmacy policies typically address the diversity of tobacco products available 
on the market.10
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The sale of tobacco products in retail pharmacies has the potential to undermine the 
promotion of patient health, especially among combustible tobacco users. More than 16 
million Americans currently live with a smoking-related illness,1 and cigarette smoking can 
complicate chronic disease management and increase the risk of adverse drug events.11–13 
Fortunately, approximately seven in ten cigarette smokers want to quit.14 Although 
pharmacies can serve as a conduit for patients to obtain evidence-based cessation support 
and U.S. Food and Drug Administration–approved medications, the concurrent sale and 
advertisement of tobacco products might counteract these resources by triggering cravings, 
stimulating impulse purchases,15 and hindering smokers’ quit attempts.
To reduce pharmacy tobacco sales, states and communities can implement policies 
prohibiting tobacco product sales in this environment. As of January 1, 2016, a total of 134 
municipalities in California and Massachusetts had enacted tobacco-free pharmacy laws.5 
Implementation of comprehensive tobacco sales prohibitions, including cigarettes and other 
tobacco products, could help reduce access to tobacco products and exposure to tobacco 
product advertising, as well as denormalize tobacco use. Initiatives to discontinue tobacco 
sales could also positively reinforce pharmacy stores’ commitment to health care. In 
addition, by eliminating concurrent tobacco product sales, pharmacies may help bring public 
awareness to the health consequences of smoking, and provide enhanced clinical 
management of tobacco-related diseases.16,17 Moreover, preliminary evaluation findings 
suggest such policies do not adversely affect business. For example, in 2014, CVS Caremark 
rebranded as CVS Health, and became the first national retail pharmacy chain to cease 
tobacco product sales. Following policy implementation, CVS reported increased year-over-
year net revenues, with positive gains in pharmacy services.18
Limitations
This study is subject to at least three limitations. First, Summer Styles is an Internet-based 
survey and may have limited generalizability compared with traditional population-based 
surveys.19 Second, data were self-reported, which could result in misreporting of measures 
such as tobacco use. Third, limited sample size prevented analysis of more nuanced tobacco 
use categories, including polytobacco use.
Conclusions
A majority of U.S. adults favor prohibiting tobacco sales in retail pharmacy stores. 
Eliminating tobacco product sales in these settings may reinforce pharmacy stores’ efforts to 
promote wellness, and further cultivate social climates that reduce the desirability, 
acceptability, and accessibility of tobacco. Prohibiting tobacco sales in pharmacies, along 
with the implementation of proven population-level tobacco control interventions, could 
help reduce tobacco-related death and disease.
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Table 2
Adjusted Prevalence Ratios of Favorability Toward Prohibiting Tobacco Product Sales in Retail Pharmacy 
Stores Among U.S. Adults, 2014a
Characteristic n (%) % (95% CI) APR (95% CI)b
Overall 4,198 66.1 (64.3, 67.8)
Sex
  Male 2,061 (49.1) 62.2 (59.7, 64.7) ref
  Female 2,137 (50.9) 69.7 (67.3, 72.0) 1.08 (1.03, 1.14)
Age (years)
  ≥65 922 (22.0) 72.2 (69.0, 75.3) ref
  45–64 1,845 (43.9) 64.8 (62.3, 67.3) 0.94 (0.88, 0.99)
  25–44 1,173 (27.9) 63.7 (60.5, 66.9) 0.91 (0.86, 0.98)
  18–24 258 (6.1) 66.8 (60.7, 73.0) 0.95 (0.86, 1.06)
Race/ethnicity
  White, NH 3,169 (75.5) 65.5 (63.6, 67.5) ref
  Black, NH 395 (9.4) 64.6 (59.1, 70.2) 1.02 (0.93, 1.12)
  Other, NH 228 (5.4) 70.4 (63.3, 77.5) 1.09 (0.99, 1.21)
  Hispanic 406 (9.7) 67.3 (62.0, 72.5) 1.07 (0.99, 1.17)
Education
  College degree 1,386 (33.0) 70.1 (67.2, 72.9) ref
  Some college 1,296 (30.9) 64.2 (61.2, 67.3) 0.95 (0.89, 1.02)
  High school 1,228 (29.2) 65.7 (62.6, 68.7) 0.99 (0.93, 1.05)
  <High school 288 (6.9) 61.7 (55.4, 68.1) 1.00 (0.89, 1.12)
Annual household income
  ≥$60,000 2,065 (49.2) 69.0 (66.7, 71.4) ref
  $40,000–$59,999 757 (18.0) 67.4 (63.5, 71.4) 1.00 (0.94, 1.07)
  $25,000–$39,999 700 (16.7) 65.8 (61.7, 70.0) 1.00 (0.93, 1.07)
  $15,000–$24,999 305 (7.3) 65.1 (59.0, 71.2) 1.01 (0.92, 1.12)
  <$15,000 371 (8.8) 48.0 (41.8, 54.2) 0.82 (0.71, 0.94)
U.S. Census regionc
  Northeast 747 (17.8) 66.7 (62.8, 70.7) ref
  Midwest 1,058 (25.2) 64.6 (61.2, 68.1) 0.99 (0.92, 1.07)
  South 1,494 (35.6) 63.9 (61.0, 66.8) 0.96 (0.89, 1.04)
  West 899 (21.4) 70.2 (66.7, 73.7) 1.02 (0.94, 1.10)
Cigarette smokingd
  Never smoker 2,241 (55.2) 71.8 (69.6, 74.1) ref
  Former smoker 1,233 (30.4) 66.3 (63.3, 69.4) 0.96 (0.90, 1.02)
  Current smoker 582 (14.4) 46.5 (41.5, 51.4) 0.73 (0.65, 0.82)
Non-cigarette tobacco productse
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Characteristic n (%) % (95% CI) APR (95% CI)b
  Never user 2,263 (54.4) 71.4 (69.2, 73.7) ref
  Former user 1,473 (35.4) 63.2 (60.4, 66.1) 0.93 (0.87, 0.99)
  Current user 421 (10.1) 47.8 (42.0, 53.6) 0.80 (0.70, 0.92)
Note: Boldface indicates statistical significance (p < 0.05).
a
Favorability defined as a report of “strongly favor” or “somewhat favor” to the question, “Do you favor or oppose banning the sale of all tobacco 
products in retail pharmacy stores?”
b
Adjusted prevalence ratios were obtained using Poisson Regression model adjusted for all covariates listed in the table.
c
Northeast: Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont. Midwest: 
Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. South: Alabama, 
Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South 
Carolina, Tennessee, Texas, Virginia, and West Virginia. West: Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New 
Mexico, Oregon, Utah, Washington, and Wyoming.
d
Current cigarette smokers are defined as respondents who smoked ≥100 cigarettes in their lifetime and reported smoking “everyday” or “some 
days” at the time of the survey. Former cigarette smokers are defined as respondents who smoked ≥100 cigarettes in their lifetime and reported 
smoking “not at all” at the time of the survey. Never cigarette smokers are defined as respondents who reported “no” to smoking ≥100 cigarettes in 
their lifetime.
e
Respondents were asked about the ever or current (past 30-day) use of the following non-cigarette tobacco products: cigars or big cigars; 
cigarillos; little cigars; chewing tobacco, snuff or dip; electronic cigarettes or e-cigarettes; electronic hookahs, hookah pens, or vape pens; some 
other electronic vapor product such as electronic cigars or electronic pipes; water pipes; roll-your-own cigarettes; flavored cigars; snus; dissolvable 
tobacco products.
APR, adjusted prevalence ratio; NH, non-Hispanic.
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